STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

[Form 4] ACCURAY INC Insider Trading Activity

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Accuray Inc. director reports RSU vesting and share acquisition

A director of Accuray Inc. (ARAY) reported the vesting and settlement of restricted stock units into common stock. On 11/21/2025, 45,620 restricted stock units converted into 45,620 shares of Accuray common stock at an exercise price of $0, reported with transaction code "M," which indicates a derivative-to-equity conversion. Following this transaction, the director beneficially owns 400,229 shares of Accuray common stock in direct form. The reported restricted stock units were a grant that was scheduled to vest 100% on 11/21/2025, with each unit representing the right to receive one share of common stock.

Positive

  • None.

Negative

  • None.
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
MAYER STEVEN F

(Last) (First) (Middle)
1240 DEMING WAY

(Street)
MADISON WI 53717

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
ACCURAY INC [ ARAY ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
11/21/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 11/21/2025 M 45,620 A $0 400,229 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Restricted Stock Units(1) $0 11/21/2025 M 45,620 (2) (2) Common Stock 45,620 $0 0 D
Explanation of Responses:
1. Each RSU represents a contingent right to receive one share of the Issuer's common stock.
2. This represents a Restricted Stock Unit that vests 100% on 11/21/2025.
Remarks:
/s/ Michael Stetler, Power of Attorney for Steven Mayer 11/25/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Accuray (ARAY) report in this Form 4?

The Form 4 reports that an Accuray director had 45,620 restricted stock units convert into 45,620 shares of common stock on 11/21/2025, recorded as a code "M" derivative-to-equity transaction at an exercise price of $0.

How many Accuray (ARAY) shares does the reporting person own after the transaction?

After the transaction, the reporting person beneficially owns 400,229 shares of Accuray common stock in direct ownership, as shown in Table I.

What is the nature of the derivative security reported for Accuray (ARAY)?

The derivative security is a grant of restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Accuray common stock, with 45,620 RSUs vesting and converting on 11/21/2025.

When did the Accuray (ARAY) restricted stock units vest?

The RSU award reported in the filing vested 100% on 11/21/2025, at which point 45,620 units were settled into the same number of common shares.

What does transaction code "M" mean in this Accuray (ARAY) Form 4?

In this context, transaction code "M" indicates the exercise or conversion of a derivative security—here, the conversion of restricted stock units into common stock.

Does the reporting person still hold any Accuray (ARAY) RSUs after this transaction?

Table II shows that after the reported transaction, the number of derivative securities (RSUs) beneficially owned is 0, indicating no remaining RSUs from this specific grant.

Accuray Incorp

NASDAQ:ARAY

ARAY Rankings

ARAY Latest News

ARAY Latest SEC Filings

ARAY Stock Data

117.87M
109.35M
2.06%
71.26%
1.97%
Medical Devices
Surgical & Medical Instruments & Apparatus
Link
United States
MADISON